Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

1993 • 23,535 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

1998 • 19,638 citations

Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years

1974 • 6,354 citations

Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor

1994 • 3,477 citations

Adipogenesis and Obesity: Rounding Out the Big Picture

1996 • 1,268 citations

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire

1993 • 1,036 citations

Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

1996 • 1,004 citations

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

1998 • 995 citations

Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus

1998 • 798 citations

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy

1998 • 797 citations

Life without white fat: a transgenic mouse

1998 • 782 citations

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice

2000 • 669 citations

Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy

2000 • 656 citations

Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation

1998 • 549 citations

Cardiac and Glycemic Benefits of Troglitazone Treatment in NIDDM

1997 • 372 citations

Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers.

1994 • 344 citations

Troglitazone action is independent of adipose tissue.

1997 • 340 citations

Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes Mellitus

1998 • 337 citations

Generalized lipodystrophy, congenital and acquired (lipoatrophy)

1996 • 302 citations

Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus

1998 • 293 citations

Effect of troglitazone on body fat distribution in type 2 diabetic patients.

1999 • 282 citations

Theory and validity of indirect calorimetry during net lipid synthesis

1988 • 276 citations

Comparison of Diabetes Diagnostic Categories in the U.S. Population According to 1997 American Diabetes Association and 1980–1985 World Health Organization Diagnostic Criteria

1997 • 269 citations

Mutational and Haplotype Analyses of Families with Familial Partial Lipodystrophy (Dunnigan Variety) Reveal Recurrent Missense Mutations in the Globular C-Terminal Domain of Lamin A/C

2000 • 268 citations

Triglyceride as a risk factor for coronary artery disease

1998 • 240 citations

Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone

1998 • 232 citations

Assessment of the composition of major body regions by dual‐energy X‐ray absorptiometry (DEXA), with special reference to limb muscle mass

1992 • 230 citations

Body composition in children: proposal for a method for calculating body fat percentage from total body density or skinfold-thickness measurements

1989 • 225 citations

Obesity and insulin resistance: Lessons learned from the Pima indians

1988 • 203 citations

Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report

2000 • 196 citations

7 Indirect calorimetry

1987 • 190 citations

A Gene for Congenital Generalized Lipodystrophy Maps to Human Chromosome 9q34

1999 • 182 citations

Familial Lipoatrophic Diabetes with Dominant Transmission<subtitle>A NEW SYNDROME<xref ref-type="fn" rid="fn1"><sup>1</sup></xref></subtitle>

1974 • 164 citations

Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21–22

1998 • 156 citations

Troglitazone Monotherapy Improves Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Randomized, Controlled Study¹

1998 • 115 citations

An Autopsy Case of Troglitazone-Induced Fulminant Hepatitis

1998 • 107 citations

Insulin resistance: the clinical spectrum.

1995 • 91 citations

Metabolic differences and the development of obesity

1995 • 85 citations

Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes.

1998 • 79 citations

Isoniazid-Related Hepatitis

1997 • 62 citations

Monogenic disorders of obesity and body fat distribution

1999 • 59 citations

Syndromes Associated with Insulin Resistance and Acanthosis Nigricans

1998 • 47 citations

Partial Lipodystrophy Associated with Juvenile Dermatomyositis: Report of Two Cases

1996 • 35 citations

No Coding Mutations Are Detected in the Peroxisome Proliferator-Activated Receptor-γ Gene in Japanese Patients with Lipoatrophic Diabetes

1997 • 23 citations

The relationship in African-Americans of sex differences in insulin-mediated suppression of nonesterified fatty acids to sex differences in fasting triglyceride levels

1997 • 20 citations